1. Home
  2. AVTX vs BGSF Comparison

AVTX vs BGSF Comparison

Compare AVTX & BGSF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVTX
  • BGSF
  • Stock Information
  • Founded
  • AVTX 2011
  • BGSF 2007
  • Country
  • AVTX United States
  • BGSF United States
  • Employees
  • AVTX N/A
  • BGSF N/A
  • Industry
  • AVTX Biotechnology: Pharmaceutical Preparations
  • BGSF Professional Services
  • Sector
  • AVTX Health Care
  • BGSF Consumer Discretionary
  • Exchange
  • AVTX Nasdaq
  • BGSF Nasdaq
  • Market Cap
  • AVTX 57.4M
  • BGSF 47.7M
  • IPO Year
  • AVTX 2015
  • BGSF N/A
  • Fundamental
  • Price
  • AVTX $4.89
  • BGSF $6.64
  • Analyst Decision
  • AVTX Strong Buy
  • BGSF Strong Buy
  • Analyst Count
  • AVTX 7
  • BGSF 1
  • Target Price
  • AVTX $31.00
  • BGSF $9.00
  • AVG Volume (30 Days)
  • AVTX 82.2K
  • BGSF 285.6K
  • Earning Date
  • AVTX 08-11-2025
  • BGSF 08-06-2025
  • Dividend Yield
  • AVTX N/A
  • BGSF N/A
  • EPS Growth
  • AVTX N/A
  • BGSF N/A
  • EPS
  • AVTX N/A
  • BGSF N/A
  • Revenue
  • AVTX $441,000.00
  • BGSF $266,968,000.00
  • Revenue This Year
  • AVTX N/A
  • BGSF $0.59
  • Revenue Next Year
  • AVTX N/A
  • BGSF N/A
  • P/E Ratio
  • AVTX N/A
  • BGSF N/A
  • Revenue Growth
  • AVTX N/A
  • BGSF N/A
  • 52 Week Low
  • AVTX $3.39
  • BGSF $2.91
  • 52 Week High
  • AVTX $16.00
  • BGSF $9.06
  • Technical
  • Relative Strength Index (RSI)
  • AVTX 54.89
  • BGSF 64.18
  • Support Level
  • AVTX $4.63
  • BGSF $5.28
  • Resistance Level
  • AVTX $5.02
  • BGSF $7.65
  • Average True Range (ATR)
  • AVTX 0.27
  • BGSF 0.54
  • MACD
  • AVTX 0.00
  • BGSF 0.05
  • Stochastic Oscillator
  • AVTX 72.73
  • BGSF 56.78

About AVTX Avalo Therapeutics Inc.

Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).

About BGSF BGSF Inc.

BGSF Inc is a national provider of consulting, managed services, and professional workforce solutions. two segments: Property Management and Professional. In the Property Management segment is a provider of office and maintenance talent. The Professional segment provides IT professionals with expertise in SAP, Workday, Peoplesoft, Hyperion, Oracle, One Stream, cyber, project management, managed services, and other IT workforce solutions to client partners on a national basis. The group generates the majority of its revenue from the Professional segment.

Share on Social Networks: